Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Industry News, A-Z
Table bottom

Google News
Table bottom

My Settings
Personal Info
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Alternative Energy
Financial Services & Investing
Economic Indicators
Commodities & Futures
International and US Foreign Trade
Obesity, Weight Control & Nutrition
Aerospace & Defense
Crime & Law Enforcement
Hospital Industry
Table bottom

Prostate Cancer
Technavio has announced its newest market research report on the global foley catheters market for the period 2018-2022, providing the latest cutting-edge insights on this popular market. This press release features...
BusinessWire, 1:28pm ET

The "Drug Analysis: Yonsa" drug pipelines has been added to's offering. Yonsa (Churchill Pharmaceuticals) is an oral, ultramicrosize tablet formulation of abiraterone acetate that inhibits 17...
BusinessWire, 12:38pm ET

The "Drug Analysis: Eligard" drug pipelines has been added to's offering. Eligard (leuprolide; Astellas/Tolmar Pharmaceuticals) is a gonadotropin-releasing hormone (GnRH) receptor agonist which...
BusinessWire, 12:38pm ET

The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market...
ABNewswire, 10:48am ET

Micromedic Technologies (TASE: MCTC) ("Micromedic"), announced successful results of a clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect® technology. The study successfully detected cells originated...
PR Newswire, 10:13am ET

3D Signatures Inc. / 3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL(TM) Test for Hodgkin's Lymphoma . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...
Globe Newswire, 8:09am ET

Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive Cancer Network(R) ("NCCN") Clinical Practice Guidelines...
BusinessWire, 8:09am ET

3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma...
GlobeNewswire, 8:08am ET

Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that the National Comprehensive Cancer Network (NCCN) has updated its medical guidelines for prostate cancer treatment to broadly include biomarker testing in prostate cancer. The changes to the...
GlobeNewswire, 7:13am ET

Merrimack Pharmaceuticals (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the formation of a new Scientific Advisory Board (SAB), comprised of world-renowned experts in precision oncology,...
PR Newswire, 7:08am ET

1-10 of 10

Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, No redistribution allowed.